{
    "2018-12-10": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报:带量采购降价超预期,板块进入估值重构和结构分化期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "带量采购",
                        "降价",
                        "估值重构",
                        "结构分化"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}